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Abstract
Purpose—To determine if the T1 relaxation time of the pancreas can detect parenchymal 
changes in mild chronic pancreatitis (CP).
Materials and Methods—This Institutional Review Board (IRB)-approved, Health Insurance 
Portability and Accountability Act (HIPAA)-compliant retrospective study analyzed 98 patients 
with suspected mild CP. Patients were grouped as normal (n = 53) or mild CP (n = 45) based on 
history, presenting symptomatology, and concordant findings on both the secretin-enhanced 
magnetic resonance cholangiopancreatography (S-MRCP) and endoscopic retrograde 
cholangiopancreatography (ERCP). T1 maps were obtained in all patients using the same 3D 
gradient echo technique on the same 3T scanner. T1 relaxation times, fat signal fraction (FSF), and 
anterior–posterior (AP) diameter were correlated with the clinical diagnosis of CP.
Results—There was a significant difference (P < 0.0001) in the T1 relaxation times between the 
control (mean = 797 msec, 95% confidence interval [CI]: 730, 865) and mild CP group (mean = 
1099 msec, 95% CI: 1032, 1166). A T1 relaxation time threshold value of 900 msec was 80% 
sensitive (95% CI: 65, 90) and 69% specific (95% CI: 56, 82) for the diagnosis of mild CP (area 
under the curve [AUC]: 0.81). Multiple regression analysis showed that T1 relaxation time was the 
only statistically significant variable correlating with the diagnosis of CP (P < 0.0001). T1 
relaxation times showed a weak positive correlation with the pancreatic FSF (ρ = 0.33, P = 0.01) 
in the control group, but not in the mild CP group.
Conclusion—The T1 relaxation time of the pancreatic parenchyma was significantly increased 
in patients with mild CP. Therefore, T1 mapping might be used as a practical quantitative imaging 
technique for the evaluation of suspected mild CP.
Chronic pancreatitis (CP) involves progressive inflammatory changes in the pancreas 
characterized by chronic unrelenting pain with episodic flares, impairment of exocrine, and 
endocrine function. A population-based study in the U.S. showed that the prevalence of CP 
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is 41/100,000, with its incidence rising mainly due to alcohol use.1 To facilitate early 
diagnosis, practical tests (eg, fecal elastase) have been developed; however, in mild 
pancreatic insufficiency, sensitivity of these tests has been found to be inadequate.2 Imaging 
of ductal morphology is crucial to establish diagnosis of CP. The Cambridge Classification 
has being used since 1984 as a reference standard to diagnose and grade CP by endoscopic 
retrograde cholangiopancreatography (ERCP) and magnetic resonance 
cholangiopancreatography (MRCP).3 Clinical use of ERCP as a purely diagnostic tool has 
declined as less invasive procedures have become available.4 Endoscopic ultrasound (EUS) 
carries less risk of complications compared to ERCP5; however, multicenter studies have 
shown that the interobserver agreement of EUS is suboptimal for the diagnosis of CP.6 
Endoscopic pancreatic function tests (ePFT) have the potential to detect CP at an earlier 
stage than other available diagnostic tests, but their use is, for the most part, limited to 
tertiary referral centers.2 Therefore, validation of a widely available, noninvasive imaging 
technique to detect early CP would have tremendous clinical benefit.
Several vendors are now offering rapid (one breath-hold) acquisition of T1 mapping 
techniques. The purpose of this study was to determine if the T1 relaxation time of the 
pancreas quantitatively measured by the T1 mapping could be a useful test for patients being 
evaluated for mild CP.
Materials and Methods
Patient Selection
The Institutional Review Board approved this retrospective study, and the requirement for 
informed consent for the patient data review was waived. A Health Insurance Portability and 
Accountability Act (HIPAA)-compliant retrospective analysis performed on patients with 
suspected pancreaticobiliary pathology presenting to the Gastroenterology Clinic in a 
tertiary referral center. Review of the electronic medical records between March 2014 and 
January 2016 identified 346 of such patients. Patients were excluded from the study if they 
were younger than 18 years of age, had diabetes mellitus, acute pancreatitis, moderate or 
severe CP, cystic or solid pancreatic neoplasm, evidence of iron overload, or cystic fibrosis. 
Following the exclusion criteria, 98 nonconsecutive patients were studied in the mild CP and 
control groups. Patients in the mild CP group (n = 45) were selected based on history of 
positive symptomatology (abdominal pain suspected to be of pancreatic origin), concordant 
ductal findings on secretin-enhanced MR cholangiopancreatigraphy (S-MRCP) and ERCP 
for mild CP according to the Cambridge Classification,3 and normal pancreatic amylase and 
lipase levels at the time of S-MRCP. Patients with normal ductal findings on S-MRCP and 
ERCP, normal amylase and lipase levels, and without history of acute or chronic pancreatitis 
were studied in the control group (n = 53). Nine patients in the control group had these 
findings not associated with any form of pancreatitis: choledocholithiasis (n = 5), sphincter 
of Oddi dysfunction (n = 3), primary sclerosing cholangitis (n = 1), and Peutz-Jeghers 
syndrome (n = 1). Average age of the patients in the control group was 55 (range: 19–84), 
versus 59 (range: 32–82) in the mild CP group. Sixty-six percent of the control group were 
female (mean age: 49, range: 19–67), versus 40% in the mild CP group (mean age: 52, 
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range: 26–84). Patients within both groups had similar body mass index, serum amylase, and 
lipase levels (Table 1).
Imaging Technique
An axial T1 mapping sequence was integrated into routine S-MRCP protocol and was 
performed in all patients. Patients fasted for at least 4 hours prior to the MR examination. 
All patients were imaged on the same 3T Magnetom Verio (Siemens Medical Solutions, 
Malvern, PA) scanner. T1 maps were acquired using a dual flip angle 3D gradient echo 
technique with the same imaging protocol and Siemens MapIt software for all the patients. 
Imaging parameters were: 48 axial slices of 4 mm thickness acquired within an 18-second 
breath-hold with repetition time (TR) of 3.87 msec, echo time (TE) of 1.32 msec, flip angle 
of 2° and 13°, acquisition matrix of 320 × 168, parallel imaging (Siemens GRAPPA) factor 
of 2, field of view of 300 × 400 mm (adjusted according to patient size), and bandwidth of 
446 Hz/pixel. Region of interest (ROI) measurements for calculation of fat signal fraction 
(FSF) were made on axial breath-hold 2-point DIXON T1-weighted images, which was 
acquired using TR of 5.45 msec, TE of 2.45 and 3.67 msec, and 9° flip angle. The secretin 
phase of the S-MRCP was performed following administration of 16 µg of secretin 
(ChiRhoStim, ChiRhoClin, Burtonsville, MD) via slow intravenous infusion over 1 minute. 
Subsequently, the pancreas was imaged using a coronal 2D single-shot turbo spin echo 
sequence (HASTE, Siemens Medical Solutions), repeated every 60 seconds for up to 10 
minutes.
Image Analysis
During the initial assessment of the patients, the largest diameter of the main pancreatic duct 
and number of ectatic branch ducts were recorded on the last image of the post-secretin S-
MRCP by a radiologist with 12 years of experience (Q.W.). Patients were included in the 
study if both ERCP and S-MRCP ductal findings indicated either normal or mild CP based 
on Cambridge Classification of CP. Subsequently, two separate fellowship-trained 
abdominal imagers with 8 and 11 years of experience, blinded to the ERCP and S-MRCP 
dataset, performed measurement of T1 relaxation time, FSF, and anterior–posterior (AP) 
diameter from the head, body, and tail of the pancreas. Special attention was given to 
drawing ROI circles (1.5 cm2) in a homogenous region of the parenchyma avoiding volume 
averaging from retroperitoneal fat, vessels, and pancreatic duct (Fig. 1). T1-weighted 
DIXON series were used for FSF and measuring AP diameter. FSF of the parenchyma was 
calculated from signal intensities (SI) of fat and water fractions using the formula:
Statistical Analysis
The two-tailed probability t-test was used to determine differences of T1 relaxation times, 
FSF, main pancreatic duct diameter, and AP diameter between the control and mild CP 
patients. One-way analysis of variance (ANOVA) was used to compare the T1 values in the 
head, body, and tail of the pancreas. A linear weighted kappa value was used to assess 
interobserver agreement. Receiver operating characteristic (ROC) curve analysis was 
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performed to determine the accuracy of the T1 relaxation time as a differentiating criterion 
for mild CP. Spearman’s rank correlation coefficient was used to assess the relationship 
between T1 relaxation times, age, AP diameter, and FSF. The significance level (α) used in 
this study was <0.05 and correlation coefficients were interpreted as: weak, 0.2; moderate, 
0.5; strong, 0.8; and perfect 1.0.7 A multiple regression model was used to analyze the 
relationship between a dependent variable (presence of mild CP) and independent variables 
(T1 relaxation time, FSF, patient’s age, and AP diameter of the pancreas). Multiple 
regression models used automatic weighting to correct for heteroscedasticity. Statistical 
analyses were performed using MedCalc v. 16.2.0 (MedCalc Software, Mariakerke, 
Belgium).
Results
Mean pancreatic ductal diameter in the control group was 2.6 mm (range: 1–3.2 mm) versus 
3.2 mm in the mild CP group (range: 2.5–3.7) (P < 0.0001). The mean number of ectatic 
side-branches in the control group was 1 (range: 0–2) versus 5 (range: 3–10) in the mild CP 
group. Serum amylase and lipase levels were within the normal range in both groups (Table 
1).
Correlation of T1 Relaxation Time and Mild Chronic Pancreatitis (Table 2)
The T1 relaxation times measured in the head, body, and tail of the pancreas were similar in 
the control (P = 0.68) and mild CP groups (P = 0.57); therefore, average values were used in 
the analysis. There was a statistically significant difference (P < 0.0001) in the mean T1 
relaxation times of the pancreas between the control (mean = 797 msec, 95% confidence 
interval [CI]: 730, 865) and mild CP groups (mean = 1099 msec, 95% CI: 1032, 1166) (Fig. 
2). Using the area under the ROC curve analysis, a T1 relaxation time threshold value of 900 
msec revealed 80% sensitivity (95% CI: 65, 90) and 69% specificity (95% CI: 56, 82) for the 
diagnosis of mild CP (area under the curve [AUC] = 0.81) (Fig. 3). There was a substantial 
interobserver agreement (kappa = 0.74, 95% CI: 0.65–0.82) for measurement of T1 
relaxation times between the two radiologists.
Correlation of Age With T1 Relaxation Time, FSF, and AP Diameter (Table 3)
There was a weak positive correlation between the age and T1 relaxation time in the control 
group (ρ = 0.28, 95% CI: 0.01, 0.51, P = 0.04) and in the mild CP group (ρ = 0.17, 95% CI: 
−0.13, 0.44, P = 0.17) (Fig. 4). There was a weak positive correlation between the age and 
FSF in the control group (ρ = 0.34, 95% CI: 0.07, 0.56, P = 0.01) and in the mild CP group 
(ρ = 0.26, 95% CI: −0.04 to 0.51, P = 0.08). There was a negative correlation between the 
age and AP diameter of the gland in the mild CP group (ρ = −0.56, 95% CI: −0.73, –0.32, P 
< 0.0001) and in the control group (ρ = −0.26, 95% CI: −0.49, 0.01, P = 0.06). The mean AP 
diameter of the pancreas was 1.1 mm larger in the control group (19.3 mm, range: 11–27 
mm) than the mild CP group (18.2 mm, range: 12–24 mm), but this was not statistically 
significant (P = 0.11).
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Correlation of FSF With T1 Relaxation Time and AP Diameter (Table 4)
We found a weak positive correlation between the T1 relaxation time and the FSF in the 
control group (ρ = 0.33, 95% CI: 0.07 to 0.55, P = 0.01), but we did not see this correlation 
in the mild CP group (ρ = 0.01, 95% CI: −0.28 to 0.31, P = 0.92). There was a weak 
negative correlation between the FSF and the AP diameter of the gland in the mild CP group 
(ρ = −0.31, 95% CI: −0.55, −0.02, P = 0.04) and in the control group (ρ = −0.26, 95% CI: 
− 0.49, 0.01, P = 0.06) (Table 4).
Multiple Regression Analysis for Diagnosis of Mild Chronic Pancreatitis (Table 5)
T1 relaxation time was the only statistically significant variable correlating with the 
diagnosis of mild CP (P < 0.0001). Patient’s age, FSF, and diameter of the gland did not 
have a statistically significant correlation with the mild CP (P = 0.22, 0.24 and 0.35, 
respectively).
Discussion
T1 mapping used to be a burdensome MRI technique, since traditional spin echo images 
required long imaging times and was difficult to accomplish when covering large volumes 
and dealing with respiratory motion.8 However, commercially available fast volumetric T1 
mapping techniques8–11 have lowered the imaging time to a single breath-hold, allowing T1 
mapping to reemerge as a potentially valuable tool in the evaluation of variety of 
pathologies. T1 mapping has been successfully used in a number of cardiac conditions 
including myocardial fibrosis and myocardial deposition diseases.12 One of the first studies 
using T1 mapping in the abdomen was done for detection of liver fibrosis.13
Previous studies reported the usefulness of different imaging techniques incorporated into S-
MRCP for the diagnosis of CP. Studies using conventional T1-weighted MR images (eg, 
gradient echo imaging) were limited by variation of the image contrast, which depends on 
the type of sequence and the imaging parameters used in different scanners. This limitation 
mandated using the signal intensity ratio (SIR), which is the ratio of pancreas to another 
organ such as spleen, paraspinal muscle, kidney, or liver. When Balci et al measured T1 SIR 
of pancreas to spleen in 24 patients and compared them to the results of endoscopic 
pancreatic function testing (ePFT), there was no statistically significant difference between 
the normal and CP groups.14 However, a recent investigation of 29 patients who underwent 
pancreatectomy reported that the T1 SIR and apparent diffusion coefficient (ADC) of the 
pancreas correlated with the degree of fibrosis.15
The T1 mapping technique used in this study should be a more reliable and accurate method 
than the conventional T1-weighted techniques since it is directly measuring the T1 relaxation 
time of the target organ. This numerical value is a tissue-specific property and it is 
independent of imaging parameters. Despite the variety of methods of image acquisition by 
different vendors, T1 relaxation times should be interchangeable across MRI machines with 
minimal variances as long as it is performed in the same strength magnet. Nevertheless, it 
may be necessary to verify this via multicenter and multivendor studies.
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Secretin is a hormone that stimulates pancreas to secrete a significant amount of pancreatic 
fluid while transiently increasing the tone of the sphincter of Oddi. If the secretin is given 
during MRCP, measuring the volume of fluid filling the duodenum has been shown to 
provide an indirect estimate of exocrine function with a sensitivity of 72% and specificity of 
87%.16,17 However, using secretin adds 12 minutes of imaging time and at least 2 minutes of 
slow intravenous infusion, as well significant cost to the study. T1 mapping acquisition takes 
only 20 seconds to acquire and therefore might have potential to be a practical imaging test 
for the diagnosis of CP without any additional cost.
Establishing a diagnosis often requires multiple imaging tests when the patient’s history and 
laboratory findings are suspicious for mild CP. Traditionally, ERCP and ePFT have been 
used as a gold standard, at least for research purposes.2 In this study the diagnosis of mild 
CP was established by combining the patient’s history, presenting symptomatology, 
laboratory tests, and concordant findings on ERCP and S-MRCP using the Cambridge 
Classification. Future studies using ePFT as the reference standard would be helpful to 
further assess the value of T1 mapping.
An important factor for imaging of CP is the presence of fatty infiltration and parenchymal 
atrophy, which are two commonly observed manifestations of the disease. Since fat tissue 
intermixing with the pancreas could interfere with the MR signal, we wanted to ensure that 
the reviewers placed ROIs on the most homogenous regions of the gland. We found the 
mean FSF of the mild CP group (8.3%) to be higher than the control group (10.4%). Our 
results concur with a recent study of 165 patients who underwent MRCP and subsequent 
pancreatectomy and reported a positive correlation between the pancreatic fibrosis and 
FSF.18 We observed a weak positive correlation between FSF and T1 signal in the control 
group; however, there was no correlation in the mild CP group. Since fat tissue has a 
significantly shorter T1 relaxation time, the presence of relatively higher FSF in CP group 
might have lowered the average values of T1 relaxation times in this group. We also looked 
into the relationship between the T1 relaxation time and other variables using multiple 
regression analysis and found that FSF, age, and diameter of the gland did not correlate with 
the diagnosis of mild CP.
This study is limited by its retrospective design, patient selection criteria, relatively small 
subject numbers, and some results being close to statistical significance. The Cambridge 
Classification used by both ERCP and MRCP has been reported to have low sensitivity for 
the detection of early CP.19,20 We used a dual flip angle, 3D gradient echo technique 
(Siemens MapIt Software) to acquire T1 maps. While this method can acquire volumetric T1 
maps within a much shorter time window, it is sensitive to B1 + field inhomogeneity.21 
Therefore, B1 + correction may be incorporated as an improvement in future studies. Also, 
the T1 relaxation time of the tissues depend on the magnetic field strength22; therefore, T1 
relaxation times should only be compared with the same strength scanners.
In conclusion, T1 mapping shows promise as a practical and relatively cost-effective 
quantitative imaging technique for the diagnosis of mild CP. It would be helpful to validate 
our results with multicenter and multivendor studies and also with other reference standards 
such as ePFT or surgical pathology.
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FIGURE 1. 
T1 maps can be displayed in color or gray scale where signal intensity of each pixel 
quantitatively encodes its T1 relaxation time. This is a gray-scale axial T1 map acquired in a 
51-year-old female with upper abdominal pain. Circular ROI measurements were obtained 
from the head, body, and tail of the pancreas. Special attention was given to drawing ROI 
circles in a homogenous region of the parenchyma avoiding volume averaging from 
retroperitoneal fat, vessels and pancreatic duct. Arrows = pancreas, L = liver, S = stomach, 
RK = right kidney, LK = left kidney.
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FIGURE 2. 
Box-and-whisker plot of T1 relaxation times in the control (mean = 797 msec, 95% CI: 730, 
865) and mild CP group (mean = 1099 msec, 95% CI: 1032, 1166). There is a statistically 
significant increase (P < 0.0001) in the average T1 relaxation time of the pancreas in mild 
CP group.
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FIGURE 3. 
ROC curve analysis for T1 relaxation time as a criterion for diagnosis of mild CP. Threshold 
value of 900 msec was 80% sensitive (95% CI: 65, 90) and 69% specific (95% CI: 56, 82) 
for the diagnosis of mild CP (AUC = 0.81).
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FIGURE 4. 
This scatterplot with regression lines shows a weak positive correlation between the age and 
T1 relaxation time of the pancreas in the control group (P < 0.01). This positive correlation 
was not observed in the mild CP group (P = 0.55).
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TABLE 1
Study Population Separated by Control and Mild CP Groups
Control (n = 53) Mild CP (n = 45)
Age 55 (Range: 19–84) 59 (Range: 32–82)
Female (F:M) 66% (35:53) 40% (18:45)
BMI 35.4 (Range: 24.1–41.4) 37.8 (Range: 25.6–42.7)
Lipase level 62 (Range: 31–173) 76 (Range: 26–156)
Amylase level 32 U/L (Range: 26–78) 44 U/L (range: 25–89)
AP diameter 19.3 mm (Range: 11–27 mm) 18.2 mm (range: 12–24 mm)
Fat signal fraction (FSF) 8.3% (95% CI: 7.2, 9.5 %) 10.4% (95%CI: 9.1, 11.7 %)
MPD diameter 2.6 mm (Range: 1.0–3.2 mm) 3.2 mm (Range: 2.5–3.7 mm)
Ectatic side-branches (#) 1 (Range: 0–2) 5 (Range: 3–10)
MPD = main pancreatic duct (average), AP = anterior-posterior, BMI = Sbody-mass index. Normal range for amylase is 20–85 U/L. Normal range 
for lipase is 0–160 U/L.
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TABLE 2
T1 Relaxation Times Within the Control and Mild CP Groups
T1 relaxation time Control (n = 53) Mild CP (n = 45)
Mean 797 msec (95% CI: 730, 865) 1099 msec (95% CI: 1032, 1166) P< 0.0001
Head 773 (SD: 269) 1047 (SD; 366) P< 0.0001
Body 803 (SD: 344) 1135 (SD: 407) P= 0.0001
Tail 827 (SD: 330) 1072 (SD: 441) P= 0.003
Average T1 relaxation time in mild CP group is significantly higher than the control group. Both the control and mild CP groups showed similar 
measurements in the head, body and tail (P = 0.68 and 0.57, respectively) therefore, average values were used in the analysis. Numbers in 
parentheses show standard deviation.
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TABLE 5
Multiple Regression Analysis Showing Correlation of the Mild CP With Other Independent Variables
Coefficient Standard
error
P
T1 relaxation time 0.0009 0.0001 <0.0001
Age 0.0031 0.0025 0.22
FSF 1.1652 0.9876 0.24
AP diameter −0.0103 0.0110 0.35
AP = anterior-posterior, FSF = fat signal fraction.
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